Zipline raises $1.5B at $21.5B valuation; DREADDs gene switch works in humans
Not Boring (Packy McCormick) · rss · 2026-11-06
Packy McCormick's weekly roundup: drone delivery firm Zipline raised $1.5B at a $21.5B valuation and signed a Walmart deal to scale to 300 supercenters; the FDA approved INOVIO's Voceryq, the first plasmid DNA immunotherapy; the first human DREADDs study cut seizures 93% in 3 epilepsy patients; and DARPA's NOM4D program demonstrated the first automated in-space assembly via a Caltech payload.
More from Venture
- Asked in a 2021 VC interview to pick one company, he chose OpenAI at $10B — curious_vii · 2026-11-06
- 5 one-person businesses you can build with an AI employee, with offers and workflows — VibeMarketer_ · 2026-11-06
- Nvidia reportedly asks TSMC to plan 3D DRAM, aimed at 2028 memory price leverage — tengyanAI · 2026-11-06
- Bill Gross launches Idealab.ai to use AI for exploring and pressure-testing business ideas — Exponential View (Azeem Azhar) · 2026-11-06
- Chord acquires Zenlytic, the BI platform behind Verizon, J.Crew and Domino's reporting — YvesMulkers · 2026-11-06
- Polymarket odds put Anthropic IPO market cap most likely at $1.5–1.75T — Polymarket · 2026-11-06